Senegal

in page functions
[French]
Senegal
Total population (2018) 16,524,421
Birth cohort (2018) 587,285
Surviving Infants (surviving to 1 year per year, 2018) 568,146
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 42/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 47/1000
World Bank Index, IDA (2015) 3.82
Gross Nation Income (per capita US$, 2015) 980
Co-financing group (2018) Initial self-financing
No. of districts/territories (2017) 76

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Senegal

Type of support

Approvals

2001-2023 (US$)
(26 Dec 2018)

Commitments

2001-2023 (US$)
(26 Dec 2018)

Disbursements

2000-2018 (US$)
(26 Dec 2018)

% Disbursed

(26 Dec 2018)
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Total $149,633,575 $152,218,553 $139,476,854
Cash Support (CASHSUPP) $145,000 $170,000 $145,000 100%
Cold Chain Equipment Optimisation Platform (CCEOP) $2,460,998 $2,460,998
Health system strengthening (HSS 1) $3,585,500 $3,585,500 $3,585,500 100%
Health system strengthening (HSS 2) $11,322,521 $13,882,499 $8,876,887 78%
HepB mono (NVS) $588,743 $588,743 $588,743 100%
HPV (NVS) $3,427,500 $3,427,500 $1,877,600 55%
HPV Demo (NVS) $202,271 $202,271 $202,271 100%
HPV MAC (NVS) $6,892,000 $6,892,000
HPV MAC - Op costs (OPC) $480,586 $480,586
Immunisation services support (ISS) $2,605,740 $2,605,740 $2,605,740 100%
Injection Safety Devices (NVS) $871,500 $871,500 $583,951 67%
Injection safety support (INS) $619,474 $619,474 $619,474 100%
IPV (NVS) $4,801,832 $4,801,832 $3,204,132 67%
Measles (NVS) $697,155 $697,155 $586,878 84%
Measles-Rubella (NVS) $4,495,177 $4,495,177 $4,495,177 100%
Meningitis A - campaign (NVS) $2,670,736 $2,670,736 $2,670,736 100%
Meningitis A - operational costs (OPC) $2,567,107 $2,567,107 $2,567,107 100%
MR - Operational costs (OPC) $4,158,500 $4,158,500 $4,158,500 100%
MR-Follow-up campaign (NVS) $1,655,661 $1,655,661 $1,655,661 100%
MR-Follow-up campaign op.costs (OPC) $1,568,884 $1,568,884 $1,568,884 100%
Penta (NVS) $44,165,763 $44,165,763 $43,685,147 99%
Pneumo (NVS) $35,866,444 $35,866,444 $43,072,548 120%
Product Switch Grant (PSG) $144,445 $144,445 $144,393 100%
Rotavirus (NVS) $10,966,038 $10,966,038 $9,908,635 90%
Vaccine Introduction Grant (VIG) $2,674,000 $2,674,000 $2,673,890 100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Senegal DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2017)

Grade of confidence


N/A
DTP3 - Official country estimates (2017) 93%
M:F sex ratio at birth (2018) 1.04
Household survey: DTP3 coverage for male (2013) 89.10%
Household survey: DTP3 coverage for female (2013) 89.60%
Household survey: Last DTP3 survey (2013) 89%
% districts achieving > 80% DTP3 coverage (2017) 84%
% districts achieving < 50% DTP3 coverage (2017) 0%
MCV WHO/UNICEF estimates (2017) 90%

Breakdown of support

Non-vaccine support Vaccine support
19% 81%
$26,945,375 $112,531,479

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Senegal

12 December 2018

MTR HE Reem Al Hashimy

Global health leaders hail immunisation as shortest path to healthy lives

Gavi Mid-Term Review closes with commitments to accelerate immunisation programmes in the poorest countries to reach more children with lifesaving vaccines.

10 December 2018

Gavi item

Parsyl and Gavi announce supply chain strengthening partnership

Gavi to make Parsyl’s quality assurance platform available in Uganda and Senegal to address last mile distribution challenge.

31 October 2018

The president of Senegal attends the first HPV vaccination during a high-level event.

200,000 girls in Senegal to be protected this year against cervical cancer

Senegal becomes the first Gavi-supported country in West Africa to introduce HPV vaccine into its routine immunisation programme.

Disclaimer: the boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of Gavi, the Vaccine Alliance concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.

close icon

modal window here